Brunsvig PF, Guren TK, Nyakas M, Steinfeldt-Reisse CH, Rasch W, Kyte JA, Juul HV, Aamdal S, Gaudernack G, Inderberg EM(2020) Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer Front Immunol, 11, 572172 DOI 10.3389/fimmu.2020.572172, PubMed 33324397
Kyte JA, Andresen NK, Russnes HG, Fretland SØ, Falk RS, Lingjærde OC, Naume B(2020) ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer J Transl Med, 18(1), 269 DOI 10.1186/s12967-020-02421-w, PubMed 32620163
Kyte JA, Røssevold A, Falk RS, Naume B(2020) ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer J Transl Med, 18(1), 252 DOI 10.1186/s12967-020-02424-7, PubMed 32576225
